Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Singlet oxygen generation via photoactivation is a photochemical process used in photodynamic therapy (PDT) to treat cancer. A photosensitizer absorbs light and transfers energy to molecular oxygen, converting it to highly reactive singlet oxygen. This reactive species induces oxidative damage, leading to tumor cell death, vascular disruption, and immune response activation. The selectivity of PDT arises from preferential accumulation of the photosensitizer in tumor tissue and localized light delivery. A key mechanism involves singlet oxygen-mediated inactivation of catalase on tumor cell membranes, reactivating ROS-mediated apoptotic pathways.
Photosensitized energy transfer from activated dye/sensitizer to molecular oxygen, generating singlet oxygen that induces oxidative damage and selective cancer cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Singlet Oxygen Generation via Photoactivation (None).